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ABSTRACT
Background: In patients with low–intermediate risk, the
use of the Framingham Risk Score (FRS) may not allow
accurate prediction of the occurrence of coronary events.
Objective: To determine whether non-invasive vascular
sonographic assessments add value to the FRS for
prediction of coronary events.
Methods: Brachial artery flow-mediated dilatation (FMD),
carotid intima–media thickness (IMT) and the presence of
carotid plaque in 70 male subjects (mean (SD) age 62 (9)
years) with a low–intermediate FRS who presented with
a recent coronary event were evaluated and compared
with those in 35 male controls matched for age (mean
age 60 (9) years).
Results: Patients with a recent coronary event had a
significantly higher FRS than controls. They had a
significantly lower FMD (3.56 (2.41)% vs 5.18 (2.69)%,
p = 0.003) and significantly higher prevalence of carotid
plaque (67% vs 40%, p = 0.008), but there was no
significant difference in mean maximum IMT between the
two groups (1.01 (0.28) vs 0.96 (0.14) mm, p = 0.32).
Multivariate analysis revealed that FMD (4.75% was an
independent predictor of an acute coronary event. Of the
three vascular markers, FMD (4.75% and presence of
carotid plaque provided the best diagnostic accuracy for a
coronary event, with area under the curve (AUC) of 0.70
and 0.64 (p = 0.001 and p = 0.033), respectively, based
on receiver operating characteristic curve analysis.
Furthermore, incorporating carotid plaque or FMD
(4.75% into the FRS (AUC = 0.72 and AUC = 0.78)
provided incremental benefit in risk stratification over FRS
alone (AUC = 0.66) (p = 0.008 and p = 0.007, for
comparison of difference in two receiver operating
characteristic curves).
Conclusions: Incorporating a measure of FMD or carotid
plaque burden with FRS significantly increases the
accuracy of predicting coronary events in subjects of low–
intermediate risk and hence should be considered as
additional investigations to improve coronary risk
assessment.
In the past, clinical prediction of cardiovascular
disease has mainly relied on evaluation of its risk
factors. On the basis of multivariate statistical
models of an individual’s cardiovascular risk
factors, different risk scores have been developed
to improve the prediction of coronary risk.1–3 The
Framingham Risk Score (FRS) is one of the most
common scoring systems used to stratify subjects
into low, intermediate or high risk of developing a
future coronary event.1 4 5 However, this method
stratifies a large and heterogeneous population of
subjects into the low–intermediate risk category, in
whom the decision to initiate primary prevention
remains unclear.6 7 Therefore, in such subjects,
additional methods for risk stratification of cardi-
ovascular disease are needed. Previous studies have
already shown that use of the Coronary Calcium
Score (CCS) determined by using cardiac CT has
incremental benefit when used in conjunction
with the FRS for risk prediction, especially in
patients in the intermediate-risk category.8 9
However, measurement of the CCS has a number
of drawbacks, including a high test cost, limited
availability and risk of exposure to radiation.
In contrast, vascular ultrasonography would be a
much more accessible tool in the primary care
setting. Various vascular ultrasonographic assess-
ments, such as brachial endothelial function,
carotid intima–media thickness (IMT) and detec-
tion of carotid plaque have already been shown to
independently predict the presence of coronary
artery disease (CAD).10–12 However, the clinical
value of these assessments above clinical risk scores
for prediction of future cardiovascular risk has not
been determined. Therefore, the purpose of this
study was to investigate the potential added
benefits of different non-invasive vascular assess-
ments (brachial endothelial function, carotid IMT
and carotid plaque detection) in conjunction with
the FRS for coronary risk prediction.
MATERIALS AND METHODS
Subjects
The study population comprised 70 consecutive
male patients with a low–intermediate coronary
risk (,10% in 10 years as determined by the FRS),
who were discharged from hospital after an acute
coronary event (including myocardial infarction
and unstable angina). Myocardial infarction was
defined as the presence of two or three of the
following: prolonged chest pain, diagnostic evolu-
tionary ECG changes, and an increase in serum
creatine kinase activity to twice the upper limit of
normal. Unstable angina was defined as the
presence of chest pain prompting hospital admis-
sion together with ischaemic ECG changes and
normal serum creatine kinase activity. All patients
had significant CAD detected by coronary angio-
gram and had received successful coronary revas-
cularisation with percutaneous coronary
intervention before discharge. Patients with pre-
existing diabetes mellitus were considered to be
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CAD equivalent and were not included in this analysis.
Furthermore, patients with a clinical history of myocardial
infarction, coronary revascularisation and angina, who died or
developed heart failure after hospitalisation, were excluded.
The control group consisted of 35 age-matched male subjects
recruited from a health screening programme. All subjects had
neither symptoms of angina nor a history of cardiovascular
disease, stroke or diabetes mellitus and had a CCS of ,10 as
detected by multi-slice cardiac CT.
All subjects were recruited between 1 July 2005 and 30 June
2006. The study was approved by the institutional review
board, and all subjects gave written informed consent.
Study design
This is a case–control study involving a Chinese patient cohort,
with or without hypertension, with an estimated low–
intermediate risk of a coronary event. The objective of the
study was to determine the value of the FRS, brachial
endothelial function and carotid ultrasound assessment, used
alone or in combination, for prediction of coronary events. In
this study, the FRS was calculated using a recalibrated version
of the risk score that has been validated for Chinese.13
Baseline demographic data, cardiovascular risk factors and
cardiovascular drugs being used at the initial presentation of
patients with CAD were documented. Cardiovascular risk
factors, including tobacco smoking, diabetes mellitus, hyperch-
olesterolaemia, hypertension, body mass index and history of
cardiovascular disease in first-degree relatives younger than 55
years of age, were assessed. Hypertension was defined as either
resting systolic or diastolic blood pressure >140/90 mm Hg at
two different times or taking medication. Diabetes mellitus was
defined as a serum fasting glucose of >7.1 mmol/l or taking
medication. Hypercholesterolaemia was defined as a fasting
total serum cholesterol concentration of >4.9 mmol/l or taking
medication. Body mass index was calculated as weight in
kilograms divided by the square of the height in metres.
Smoking status was recorded as either smoker (past and current)
or non-smoker. Fasting serum glucose and lipid concentrations
were determined in controls and in patients within 24 h of their
initial presentation of the acute coronary event.
Vascular ultrasound studies
Vascular ultrasound examinations were performed within
3 weeks of initial presentation in patients with CAD. Brachial
endothelial function, carotid IMT and presence of carotid
plaque were evaluated through a standard B-mode ultrasound
examination with the use of a 7.5 MHz linear array transducer
and a high-resolution ultrasound system (Agilent Sonos 5500;
Philips, Andover, Massachusetts, USA) as described previously.14–16
A single experienced operator, who was blinded to the identity of
the study subjects, performed all the vascular ultrasound
examinations.
Brachial endothelial function
Patients were studied in the fasting state, and vasoactive drugs
were withheld for 12 h before the scans. Longitudinal brachial
artery diameter was obtained at rest, and then during flow-
mediated dilatation (FMD), induced by inflation of a pneumatic
tourniquet placed on the forearm to a pressure of 50 mm Hg
above systolic blood pressure for 5 min. The cuff was then
released, and serial images of the brachial artery were recorded
for 5 min. Finally, brachial artery diameter was measured again
at 4 min after administration of 400 mg sublingual nitroglycer-
ine spray. FMD was defined as the percentage change in brachial
artery diameter between 1 min after cuff deflation and baseline.
All digital images were stored on optical diskettes for
subsequent off-line analysis using a computer workstation
(EchoPAC; GE Medical Systems, Milwaukee, Wisconsin, USA).
The brachial artery diameter was measured by a single operator,
and the mean of three consecutive measurements was calculated.
The intra-observer correlation coefficient for FMD was 0.90 (two
repeated measurements in 20 randomly chosen subjects).
Carotid IMT
Carotid IMT was determined by measuring manually the
distance between the lumen–intima and media–adventia border
of the vascular wall using electronic callipers. Each ultrasonic
scan was performed in the anterior, lateral and posterior
projections of the right and left carotid arteries. Three IMT
measurements were made on the near and far wall of the
common carotid arteries, carotid bifurcation and internal
carotid arteries. The mean maximum IMT (mmIMT) was used
for analysis and was calculated by averaging the values of
maximum IMT measured from 12 pre-selected segments in the
carotid arteries. Presence of carotid plaque was defined as an
endoluminal protrusion of the arterial lumen of at least 0.5 mm
or 50% of the surrounding IMT value or IMT of .1.5 mm.17
The intra-observer coefficient of variation and correlation
coefficient for mmIMT were 4.2% and 0.97, respectively (two
repeated measurements in 20 randomly chosen subjects).
Cardiac CT CCS
Cardiac CT was performed in all control subjects from the base
of the heart to the apex in one breath-hold in the supine
Table 1 Clinical characteristics and vascular assessment variables of
the study population
Characteristic
CAD
(n = 70)
Controls
(n = 35) p Value
Age (years) 62.4 (8.5) 59.5 (8.9) 0.11
Male 70 (100%) 35 (100%) 1.00
Body mass index (kg/m2) 25.1 (3.3) 24.0 (3.1) 0.12
Blood pressure (mm Hg)
Systolic 126.3 (16.6) 122.6 (16.1) 0.28
Diastolic 74.0 (8.9) 75.1 (9.4) 0.58
Hypertension 42 (60%) 9 (26%) 0.001
Hypercholesterolaemia 58 (83%) 19 (54%) 0.002
Smoking 38 (54%) 15 (43%) 0.27
Family history of cardiovascular disease 9 (13%) 1 (3%) 0.10
FRS (%) 3.29 (2.23) 2.06 (1.21) 0.003
Biochemistry analysis
Total cholesterol (mmol/l ) 4.80 (1.00) 4.93 (0.70) 0.50
LDL (mmol/l) 2.92 (0.83) 3.08 (0.68) 0.33
HDL (mmol/l) 1.14 (0.25) 1.27 (0.31) 0.031
Triglyceride (mmol/l) 1.58 (1.24) 1.24 (0.48) 0.13
Blood glucose (mmol/l) 5.27 (0.86) 5.04 (0.42) 0.13
Drugs
Anti-hypertensives 62 (89%) 10 (29%) ,0.001
Lipid-lowering therapy 55 (79%) 1 (3%) ,0.001
Vascular assessment variables
FMD (%) 3.56 (2.41) 5.18 (2.69) 0.003
mmIMT (mm) 1.01 (0.28) 0.96 (0.14) 0.32
Carotid plaque 47 (67%) 14 (40%) 0.008
Values are mean (SD) or number (%).
CAD, coronary artery disease; FMD, flow-mediated dilatation; FRS, Framingham Risk
Score (10-year calculated risk of developing a coronary event); HDL, high-density
lipoprotein; LDL, low-density lipoprotein; mmIMT, mean maximum intima–media
thickness.
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position using a Light speed (LX16) General Electric (GE) CT
scanner (GE Medical Systems). Scan parameters included slice
thickness 2.5 mm (eight images collected simultaneously), cine
scan mode, 0.05 s cine time interval, 120 Kv, 300 mAs (0.5 s per
rotation), and cardiac gating with prospective triggering. Data
were transferred to Advantage Workstation 4.2 for post-
processing, and calculation of the CCS was performed using
GE cardiac software.
Statistical analysis
For power calculation, we required 62 subjects to ensure that
the true value lay within 0.2 of our estimate to determine the
true sensitivity and specificity of 0.5 with 5% significant level
and 80% power.
Continuous variables are presented as mean (SD). Categorical
data are presented as frequencies and percentages. Statistical
comparisons between groups were performed with the Student
t test for continuous variables and x2 test for categorical
variables. Correlations between variables were evaluated by
calculating the Spearman correlation coefficient, as mmIMT
and FMD did not follow normal distribution. A univariate
binary logistic regression model was used to identify risk factors
associated with a coronary event, then stepwise forward
multivariate binary logistic was used to identify independent
predictors of a coronary event. Receiver operating characteristic
(ROC) curves were constructed, and the areas under the curve
(AUC) as well as the sensitivities, specificities, positive and
negative predictive values of the diagnostic test were obtained.
Calculations were performed with use of SPSS V13.0 software,
and the difference in AUC between two ROC curves was
calculated with MedCalc 8.2.1.0 software. p,0.05 was con-
sidered to be significant.
RESULTS
Clinical characteristics
As shown in table 1, patients with CAD and controls were
matched by age; all were male. Patients with CAD had a higher
prevalence of hypertension (p = 0.001) and hypercholesterolae-
mia (p = 0.002) than controls. Furthermore, patients had
significantly lower high-density lipoprotein than controls
(p = 0.031). However, there were no differences in prevalence
of smoking (p = 0.27), family history of cardiovascular disease
(p = 0.10) or body mass index between the two groups
(p = 0.12). For the 10-year predicted risk of developing a
coronary event calculated from the FRS, patients with CAD
had a significantly higher risk score than controls (p = 0.003). As
expected, patients were more likely to have received drugs for
treatment of hypertension and hypercholesterolaemia (both
p,0.001).
Vascular assessment variables
Patients with CAD had a significantly lower brachial FMD than
controls (3.56 (2.41)% vs 5.18 (2.69)%, p = 0.003). They also had
a significantly higher prevalence of carotid plaque than controls
(67% vs 40%, p = 0.008), but there was no significant difference
in mmIMT between the two groups (1.01 (0.28) vs 0.96
(0.14) mm, p = 0.32).
As shown in fig 1, there was a modest but significant positive
correlation between mmIMT and FRS (r = 0.314, p = 0.001),
and negative correlation between FMD and FRS (r =20.246,
p = 0.016). Furthermore, FMD correlated inversely with
mmIMT (r =20.226, p = 0.026).
Table 2 summarises the diagnostic and optimal cut-off values
of the FRS and individual vascular assessment variables for
coronary event prediction obtained from ROC curve analysis.
The FRS was identified to have moderate diagnostic value for
coronary event prediction with an AUC of 0.66 (p = 0.007). Of
the vascular assessment variables, FMD had the best diagnostic
accuracy, with an AUC of 0.70 (p = 0.001). Presence of carotid
plaque was also shown to have moderate diagnostic value, with
an AUC of 0.64 (p = 0.033), but mmIMT was identified to be a
poor diagnostic test, with an AUC of 0.54 (p = 0.49).
Figure 1 Correlations between (A) mean maximum carotid intima–
media thickness (mmIMT) and Framingham Risk Score (FRS), (B) flow-
mediated dilatation (FMD) and FRS, and (C) FMD and mmIMT.
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Incremental benefit of vascular markers for coronary risk
prediction
As shown in fig 2, the combination of FRS with either carotid
plaque (AUC = 0.72) or FMD (4.75% (AUC = 0.78) provided
significant incremental benefit for coronary event prediction
compared with FRS alone (AUC = 0.66, comparison with FRS +
carotid plaque, p = 0.008; comparison with FRS + FMD
(4.75%, p = 0.007, for comparison of two ROC curves).
However, the combination of mmIMT >1.05 mm with FRS
did not provide any incremental benefit (AUC = 0.69, p = 0.18
for comparison with ROC curve of the FRS). The combination
of both carotid plaque and FMD (4.75% with the FRS achieved
an AUC of 0.75 (p,0.001) but did not provide further
improvement compared with the use of either vascular marker
alone (comparison with FRS + FMD (4.75%, p = 0.34,
comparison with FRS + carotid plaque p = 0.060).
Univariate analysis revealed that the FRS, hypertension,
hypercholesterolaemia, impaired FMD and presence of carotid
plaque predicted the occurrence of coronary events (table 3).
Multivariate analysis showed that FRS (odds ratio (OR) 1.45,
95% CI 1.03 to 2.05, p = 0.034), hypercholesterolaemia (OR
4.80, 95% CI 1.67 to 13.65, p = 0.003) and impaired FMD (OR
7.97, 95% CI 2.69 to 23.59, p = 0.000) were independent
predictors of a coronary event, but hypertension and presence
of carotid plaque were not.
DISCUSSION
The results of this study show that the use of various vascular
assessments improved risk stratification in low–intermediate
risk patients as determined by the FRS. Of the different vascular
assessment variables, brachial FMD was superior to the FRS,
carotid IMT or the presence of carotid plaque for predicting
coronary events. Furthermore, impaired FMD was an indepen-
dent predictor of coronary events beyond the information
provided by the FRS. However, the combination of both
brachial FMD and presence of carotid plaque with the FRS did
not further improve the predictive value. Used independently,
an impaired brachial FMD or identification of carotid plaque
provided added value to risk stratification when used together
with the FRS. This finding therefore raises the potential of using
vascular markers for coronary risk stratification in the future.
Recent clinical guidelines have recommended the incorpora-
tion of CCS, carotid IMT and carotid plaque as ‘‘atherosclerosis
tests’’ to risk-stratify the presence of CAD in apparently healthy
subjects.18 However, studies have revealed a weak correlation
between carotid IMT and the extent of CAD.19 Carotid plaque,
in contrast, has been shown to be superior to CCS and carotid
IMT for prediction of significant CAD and hence a better
surrogate marker for predicting coronary events.20 In this study,
there was no significant difference in carotid mmIMT between
patients with CAD and controls, but as expected, patients with
CAD had a significantly higher prevalence of carotid plaque. On
the other hand, our results have shown that the brachial
Table 2 Diagnostic values of the Framingham Risk Score and vascular assessment variables according to specified cut-off values
Marker AUC (SD) p Value
Cut-off
values
Sensitivity
(95% CI)
Specificity
(95% CI)
Positive
predictive
value
Negative
predictive
value
FRS 0.66 (0.06) 0.007 >2.50 56.7 (44.0 to 68.8) 74.3 (56.7 to 87.5) 80.9 47.3
FMD 0.70 (0.06) 0.001 (4.75 81.5 (70.0 to 90.1) 60.0 (42.1 to 76.1) 79.1 60.0
Carotid plaque 0.64 (0.05) 0.033 67.1 (54.9 to 77.9) 60.0 (42.1 to 76.1) 77.0 47.7
mmIMT 0.54 (0.06) 0.492 >1.05 34.8 (23.7 to 47.2) 82.9 (66.3 to 93.4) 80.0 39.2
FRS + FMD (4.75 0.78 (0.05) 0.000 – 76.2 (63.8 to 86.0) 68.6 (50.7 to 83.1) 81.4 61.5
FRS + carotid plaque 0.72 (0.05) 0.000 – 83.6 (72.5 to 91.5) 62.9 (44.9 to 78.5) 81.2 66.7
FRS + mmIMT >1.05 0.69 (0.05) 0.000 – 69.7 (57.1 to 80.4) 68.6 (50.7 to 83.1) 80.7 54.5
FRS + FMD (4.75+ carotid plaque 0.75 (0.05) 0.000 – 81.0 (69.1 to 89.7) 68.6 (50.7 to 83.1) 82.3 66.7
FRS + carotid plaque + mmIMT >1.05 0.73 (0.05) 0.000 – 75.8 (63.6 to 85.5) 71.4 (53.7 to 85.3) 83.3 61.0
AUC, area under curve; FMD, flow-mediated dilatation; FRS, Framingham Risk Score; mmIMT, mean maximum intima–media thickness.
Figure 2 Receiver operating characteristic (ROC) curves to illustrate
the incremental benefit achieved by adding presence of carotid plaque or
an impaired flow-mediated dilatation (FMD) of (4.75% to the
Framingham Risk Score (FRS) for coronary risk prediction. AUC, area
under the curve.
What this study adds
Non-invasive vascular sonographic assessments (brachial FMD
and carotid plaque detection) provide incremental value when
used with the FRS in risk stratification of developing a coronary
event in low–intermediate risk subjects.
What is already known on this topic
c Coronary calcium score has incremental benefit when used in
conjunction with the Framingham Risk Score (FRS) for
coronary risk prediction, especially for subjects of
intermediate risk.
c Various non-invasive vascular sonographic assessments
(brachial flow-mediated dilatation (FMD), carotid intima–
media thickness and carotid plaque) independently predict the
presence of coronary artery disease.
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endothelial function test is superior to the FRS, carotid IMT or
plaque detection for predicting coronary events. This finding
suggests that vascular endothelial function is more important
than the extent of atherosclerosis or overall clinical risk profile
in determining the risk of acute coronary events in a low–
intermediate risk population.
Previous studies have shown that FMD and carotid athero-
sclerosis provide distinct independent information about ather-
osclerosis.21 22 Whereas FMD identifies abnormalities of the
endothelial function preceding development of an anatomical
lesion, carotid IMT and plaque formation indicate the presence
of a histological abnormality, suggestive of a more advanced
stage of atherosclerosis. Furthermore, FMD is most closely
correlated to cardiovascular risk factors and estimated 10-year
coronary heart disease risk in subjects at a low risk of a coro-
nary event.23 Consistent with these findings, we have shown
that, of the surrogate markers tested, FMD has the best
predictive value and provides incremental value when used with
the FRS in risk stratification of developing a coronary event in
low–intermediate risk patients, in the presence or absence of
hypertension.
There are several limitations in this study. This was a
retrospective study which consisted of a small number of
patients who presented with acute coronary events. Only male
Chinese subjects were studied, hence our results might not be
applicable to women or other ethnic groups. Therefore, the
clinical prediction values of different non-invasive vascular
sonographic assessments need to be confirmed by future
prospective studies in a larger patient cohort with low–
intermediate FRS involving subjects of both genders.
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FRS 1.50 (1.13 to 2.00) 0.006 1.45 (1.03 to 2.05) 0.034
Hypertension 4.33 (1.77 to 10.62) 0.001
Hypercholesterolaemia 5.28 (2.20 to 12.68) 0.000 4.80 (1.67 to 13.65) 0.003
Smoking 1.58 (0.70 to 3.59) 0.27
FMD (4.75 6.63 (2.64 to 16.66) ,0.001 7.97 (2.69 to 23.59) ,0.001
mmIMT >1.05 2.58 (0.94 to 7.07) 0.066
Carotid plaque 3.07 (1.32 to 7.10) 0.009
FMD, flow-mediated dilatation; FRS, Framingham Risk Score; mmIMT, mean maximum intima–media thickness.
Suggestions for future studies on this topic
Larger scaled prospective studies to confirm the potential of
vascular sonographic assessments in coronary risk stratification.
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